Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shanchol Boosting Regimen in Previously Immunized Adults and Children
NCT01579448Phase 4Completed
- Start
- Dec 2012
- Primary completion
- Jul 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of cholera vaccine (inactivated, oral) in cholera (3 arms). Primary endpoint: Immunogenicity provided by a two dose boosting regimen of Shanchol™ at 28 days. Started Dec 2012; status: completed.
02
Drugs
cholera vaccine (inactivated, oral)
03
Conditions
cholera
Beyond the preview
Go deeper on NCT01579448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01579448.